NOS2 and Hyperglycemia: An increasing amount of evidence has demonstrated that hyperglycemia increases the expression of inflammatory and oxidative stress markers such as proinflammatory cytokines, iNOS, and reactive oxygen species, which correlate with disease progression and decline in neurological function [36].